Characteristics of COPPAR Study Subjects at Time of Enrollment
387 Patients(PsA patients: 259, PsO patients: 128) Enrolled as of Feb 2024
Disease Characteristics
CAPP: Comprehensive Assessment of the Psoriasis Patient, DLQI: Dermatology Life Quality Index, MD CAPP Score: Comprehensive assessment of the psoriasis patient Inverse (Intertriginous) PsO Assessment, MDHAQ: Multi-Dimensional Health Assessment Questionnaire, NAPSI: Nail Psoriasis Severity Index, Dactylitis Score:: Dactylitis Assessment, Itch Assessment: Itch Intensity Assessment, LEEDS Enthesis Index: Joint Assessment, Pain VAS: Pain Visual Analogue Scale, Patient Global: Patient Global Assessment, Skin Global: Patient Skin Global Assessment, Patient Global Joint: Patient Global Assessment-Psoriatic Arthritis, PPPGA: Palmoplantar Psoriasis Physician Global Assessment, ScPGA: Scalp Physician Global Assessment, sPGA: Static Physician’s Global Assessment, SPGAG: Static Physician Global Assessment of Genitalia, PASI: Psoriasis Area and Severity Index, RAPID3: Routine Assessment of Patient Index Data 3, BSA: body surface area, Total Painful Joints/Total Swollen Joints: 68/66 Joint Count
CAPP: Comprehensive Assessment of the Psoriasis Patient, DLQI: Dermatology Life Quality Index, MD CAPP Score: Comprehensive assessment of the psoriasis patient Inverse (Intertriginous) PsO Assessment, NAPSI: Nail Psoriasis Severity Index, Itch Assessment: Itch Intensity Assessment, Skin Global: Patient Skin Global Assessment, ScPGA: Scalp Physician Global Assessment, sPGA: Static Physician’s Global Assessment, SPGAG: Static Physician Global Assessment of Genitalia, PASI: Psoriasis Area and Severity Index, BSA: body surface area,